Últimos testes

EudraCT Number: 2006-004632-69

Sponsor Protocol Number: P060309

Start Date: 2006-12-04

Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

Full Title: Polymorphismes du gène codant pour le cytochrome 2C19 et réponse au clopidogrel chez le sujet sain

Medical condition: volontaire sain

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10043414	Therapeutic response decreased	PT

Population Age: Adults

Gender: Male

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-002060-26

Sponsor Protocol Number: 1401201

Start Date: 2006-12-04

Sponsor Name: Intendis GmbH

Full Title: A double-blind, randomized, vehicle-controlled, 6-week exploratory multicenter pilot study of the efficacy and safety of Azelaic Acid (AzA) 15% gel in the topical treatment of mild to moderate seb...

Medical condition: Patients with mild to moderate seborrheic dermatitis of the facial area and meeting the specific eligibility criteria

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10012488	Dermatitis seborrheic	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2006-004465-33

Sponsor Protocol Number: Cox052006

Start Date: 2006-12-04

Sponsor Name: Eero Kaasinen

Full Title: Oral Celecoxib combined with BCG instillation therapy in treatment of carcinoma in situ (CIS), TaG3 and T1 disease of urinary bladder

Medical condition: invasive bladder cancer

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10005014	Bladder carcinoma	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FI (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-003577-27

Sponsor Protocol Number: A6631007

Start Date: 2006-12-01

Sponsor Name: Pfizer Luxembourg SARL Branch Office Estonia

Full Title: A 12-WEEK, PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED STUDY TO INVESTIGATE THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF PH-797804, ADMINISTERED ORALLY ONCE DAILY IN SUBJECTS WITH ACTIVE...

Medical condition: Treatment of rheumatoid arthritis (RA)

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10039073	Rheumatoid arthritis	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: EE (Completed) CZ (Completed) ES (Completed)

Trial results: View results

EudraCT Number: 2006-002361-39

Sponsor Protocol Number: BAY 79-4998 / 12331

Start Date: 2006-12-01

Sponsor Name: Bayer Vital GmbH

Full Title: A 4-week, open-label, multicenter, urodynamic pilot study to explore the efficacy, tolerability and safety of darifenacin (7.5 mg with up-titration to 15 mg) in patients with multiple sclerosis and...

Medical condition: Neurogenic overactive bladder disaese in patients with multiple sclerosis

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10059617	Overactive bladder	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: View results

EudraCT Number: 2006-003121-82

Sponsor Protocol Number: 4351

Start Date: 2006-12-01

Sponsor Name: University Hospital Southampton NHS Foundation Trust

Full Title: A prospective randomised open label trial of oxaliplatin / irinotecan plus fluorouracil versus oxaliplatin / irinotecan plus fluorouracil and cetuximab pre and post operatively in patients with res...

Medical condition: Colorectal Cancer Liver Metastasis

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)	10052358	Colorectal cancer metastatic	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: (No results available)

EudraCT Number: 2005-001446-16

Sponsor Protocol Number: F05-TdI-301

Start Date: 2006-12-01

Sponsor Name: Sanofi Pasteur MSD

Full Title: Comparison of the immunogenicity and safety of a combined adsorbed low dose diphtheria, tetanus and inactivated poliomyelitis vaccine (REVAXIS®) with a combined diphtheria, tetanus and inactivated ...

Medical condition: Not applicable - Healthy volunteers - 6 year-old child

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Under 18

Gender: Male, Female

Trial protocol: FR (Completed)

Trial results: View results

EudraCT Number: 2006-001608-35

Sponsor Protocol Number: HUM-04-80

Start Date: 2006-12-01

Sponsor Name: Dr. Valérie gangji

Full Title: TREATMENT OF SCIATICA BY ADALIMUMAB INJECTION : A RANDOMIZED, DOUBLE BLIND CONTROLLED TRIAL.

Medical condition: To determine the efficacy of adalimumab in disc herniation-induced sciatica in a controlled randomised double blind pilot study.

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10039674	Sciatica	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: BE (Completed)

Trial results: (No results available)

EudraCT Number: 2006-002245-36

Sponsor Protocol Number: MKC-TI-103

Start Date: 2006-12-01

Sponsor Name: MannKind Corporation

Full Title: A Phase 3, 24-Week, Multi-Center, Open-Label, Randomized, Controlled Trial Comparing the Efficacy and Safety of Prandial Inhalation of Technosphere®/Insulin in Combination with Metformin or Technos...

Medical condition: Diabetes mellitus type II

Disease:	Version	SOC Term	Classification Code	Term	Level
	8.1		10012601	Diabetes mellitus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed) ES (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-004510-41

Sponsor Protocol Number: GEICAM/2006-03

Start Date: 2006-12-01

Sponsor Name: GEICAM (GRUPO ESPAÑOL DE INVESTIGACION EN CANCER DE MAMA)

Full Title: ESTUDIO MULTICÉNTRICO FASE II DE DISTRIBUCIÓN ALEATORIA, PARA EVALUAR LA EFICACIA DE TRATAMIENTO NEOADYUVANTE SELECTIVO SEGÚN SUBTIPO INMUNOHISTOQUÍMICO EN CÁNCER DE MAMA HER2 NEGATIVO

Medical condition: Pacientes con cáncer de mama primario operable o localmente avanzado que presenten tumores mayores o iguales a 2 cm de diámetro o menores de 2 cm y afectación axilar.

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10057654	Breast cancer female	PT

Population Age: Adults, Elderly

Gender: Female

Trial protocol: ES (Ongoing)

Trial results: (No results available)

Últimos testes

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas